文献速递耳科与耳神经小儿耳鼻咽喉

年轻成人新发感音神经性听力损失中在线粒体病检测的重要性

The Importance of Mitochondrial Disease Testing in Young Adults With New Onset Sensorineural Hearing Loss.
PubMed 文献 · Ear Hear · 2023-11-06

该研究回顾了49例接受线粒体病基因检测患者的临床与听力资料,发现分子确诊线粒体病者中三分之一以感音神经性听力损失为首发表现,听力损失平均早于基因检测至少10年;听力图表现为低频轻中度、2 kHz及以上频率中度感音神经性听力损失。作者提出感音神经性听力损失筛查可能是线粒体病的早期指标,其听力图特征或可用于临床分诊。

要点

  • 分子确诊线粒体病患者中三分之一以感音神经性听力损失为首发表现。
  • 患者听力损失平均早于线粒体病基因检测至少10年。
  • 听力图表现为低频轻中度、2 kHz及以上频率中度感音神经性听力损失。

核心结论

  • 本研究提示感音神经性听力损失筛查可能是线粒体病的早期指标。
  • 作者提出线粒体病确诊者的听力图特征可能具有临床分诊用途。

研究设计与样本

  • 回顾性分析49例接受线粒体病基因检测患者的临床与听力学资料。

主要发现

  • 分子确诊线粒体病的个体中三分之一以感音神经性听力损失为首发表现。
  • 患者听力损失平均早于基因检测至少10年。
  • 听力图整体表现为低频轻中度感音神经性听力损失,2 kHz及以上频率为中度感音神经性听力损失。

临床怎么用

  • 作者建议在最早发现感音神经性听力损失时进行基因检测,可能有助于更早诊断线粒体病。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sensorineural hearing loss (SNHL) occurs commonly as part of mitochondriopathies and varies in severity and onset. In this study, we characterized hearing with specific consideration for hearing loss as a potential early indicator of mitochondrial disease (MD). We hypothesize that genetic testing at the earliest detection of SNHL may lead to an earlier MD diagnosis. DESIGN: We reviewed the clinical and audiometric data of 49 patients undergoing genetic testing for MD. RESULTS: One-third of individuals with molecularly confirmed MD presented with SNHL. On average, patients had hearing loss at least 10 years before genetic testing. The collective audiometric profile includes mild to moderate SNHL at lower frequencies and moderate SNHL at 2 kHz and higher frequencies. CONCLUSIONS: This study suggests that screening for SNHL could be an early indicator of MD. We propose that the audiometric profile for those with a MD diagnosis may have clinical triage utility.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Koleilat A, Poling GL, Schimmenti LA, et al. The Importance of Mitochondrial Disease Testing in Young Adults With New Onset Sensorineural Hearing Loss. Ear Hear. 2023. PMID: 37930162. doi:10.1097/AUD.0000000000001442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。